| 63. |
Paranjape , S.A. , Vavaiya, K., Kale, A.Y, Briski, K.P.* (2005) Role of Dorsal Vagal Motor Nucleus Orexin-A Receptor in Glycemic Responses
to Acute Versus Repeated Insulin Administration. Amer. J. Physiol., submitted. |
| 62. |
Vavaiya, K.V., Paranjape, S.A, Briski, K.P* (2005) Nonuniform Monocarboxylate Transporter-2 Expression in the Hindbrain Dorsal
Vagal Complex during Recurrent Insulin-Induced Hypoglycemia: Impact of Gender. NeuroReport,
submitted. |
| 61. |
Briski, K.P.*, Singh S.R. (2005) Hindbrain neuroglucopenia elicits site-specific transcriptional
activation of glutamate decarboxylase immunopositive neurons in rat septopreoptic
area. J. Neuroendocrinology, under revision. |
| 60. |
Kale, A.Y, Paranjape, S.A., Briski, K.P.* (2005) Intracerebroventricular administration of the nonsteroidal glucocorticoid
receptor antagonist, CP4-72555, prevents exacerbation of hypoglycemia during repeated
insulin administration. Neuroscience, revision under review. |
| 59. |
Paranjape , S.A. , Kale, A.Y., Briski, K.P.* (2005) Habituation of insulin-induced hypoglycemic transcription activation
of lateral hypothalamic orexin-A-containing neurons to recurring exposure. Regul.
Pept., in press |
| 58. |
Patil, G.D., Briski, K.P.* (2005) Induction of Fos immunoreactivity labeling in forebrain metabolic loci
by caudal fourth ventricular administration of the monocarboxyate transporter inhibitor,
α-cyano-4-hydroxycinnamic acid. Neuroendocrinology, 82: 49-57. |
| 57. |
Patil, G.D., Briski, K.P.* (2005) Lactate is a critical 'sensed' variable in caudal hindbrain monitoring
of CNS metabolic stasis. Amer. J. Physiol., 289: R1777-86. |
| 56. |
Sylvester, P.W., Shah, S.J., Haynie, D.T., Briski, K.P.* (2005) Effects of ultra-wide band electromagnetic pulses on pre-neoplastic mammary
epithelial cell proliferation. Cell Proliferation, 38: 153-63. |
| 55. |
Singh, S.R., Briski, K.P.* (2005) Central GABAA, but not GABAB receptors mediate suppressive effects of caudal
hindbrain glucoprivation on the LH surge in the steroid-primed, ovariectomized female
rat. J. Neuroendocrinol., 17: 407-12. |
| 54. |
Patil, G.D., Briski, K.P.* (2005) Transcriptional activation of nucleus tractus solitarius/area postrema
catecholaminergic neurons by pharmacological inhibition of caudal hindbrain monocarboxylate
transporter function. Neuroendocrinology, 81:96-102. |
| 53. |
Paranjape , S.A. , Briski, K.P.* (2005) Recurrent insulin-induced hypoglycemia causes site-specific patterns of
habituation or amplification of CNS neuronal genomic activation. Neuroscience, 130:
957-970. |
| 52. |
Singh, S.R., Briski, K.P.* (2004) Septopreoptic mu opioid receptor mediation of hindbrain glucoprivic inhibition
of reproductive neuroendocrine function in the female rat. Endocrinology, 145: 5322-5331. |
| 51. |
Singh, S.R., Briski, K.P.* (2004) Caudal hindbrain glucoprivation enhances GABA release in discrete septopreoptic
structures in the steroid-primed ovariectomized rat brain: Role of mu opioid receptors.
Neuroendocrinology, 80: 201-209. |
| 50. |
Sylvester, P.W., Nachnani, A., Shah, S., Briski, K.P.* (2002) Role of GTP-binding proteins in reversing the antiproliferative effects
of tocotrienols in preneoplastic mammary epithelial cells. Asia Pac J Clin Nutr.,
11 Suppl 7: S452-9. |
| 49. |
Briski, K.P.* (2002) Hindbrain glucoprivic inhibition of the proestrus luteinizing hormone surge
in the female rat is attenuated by exogenous lactate administration. Neurosci. Res.
Comm., 31: 67-73. |
| 48. |
Briski, K.P.*, Hollerman, W.A., Glass, G.A. (2002) Nuclear microprobe analysis of transmembrane
ion flux in rat brain. Proceedings, Material Research Society, Vol. 711 Symposium
FF: Advanced Biomaterials - Characterization, Tissue Engineering and Complexity.
pp. 119-124. |
| 47. |
Sylvester, P.W., Mcintyre, B.S., Gapor, A., Briski, K.P.* (2001) Vitamin E inhibition of normal mammary epithelial cell growth is associated
with a reduction in protein kinase C(alpha) activation. Cell Proliferation, 34: 347-57. |
| 46. |
Briski, K.P.*, Marshall , E.S. (2001) Induction of ependymal, glial, and neuronal transactivation
by intraventricular administration of the SGLT1 Na+-D-glucose cotransporter inhibitor,
phlorizin. Neurochem. Res., 26(7): 783-92. |
| 45. |
Briski, K.P.*, Gillen, E. (2001) Differential Fos expression within the male rat preoptic area
and hypothalamus in response to physical vs. psychological stress. Brain Res. Bull.,
55: 410-408. |
| 44. |
Briski, K.P.*, Sylvester, P.W. (2001) Codistribution of Fos- and mu opioid receptor immunoreactivity
within the rat septopreoptic area and hypothalamus during acute glucose deprivation;
effects of CTOP pretreatment. Neurosci. Lett., 306(3): 141-4. |
| 43. |
Briski, K.P.*, Marshall , E.S., Sylvester, P.W. (2001) Effects of estradiol on glucoprivic transactivation
of catecholaminergic neurons in the female rat caudal brainstem. Neuroendocrinology,
73(6): 369-377. |
| 42. |
Briski, K.P.*, Sylvester, P.W. (2001) Hypothalamic orexin-A-immunpositive neurons express Fos
in response to central glucopenia. NeuroReport, 12: 531-534. |
| 41. |
Mcintyre, B.S., Briski, K.P.*, Gapor, A., Sylvester, P.W. (2000) Antiproliferative and apoptotic effects of
tocopherols and tocotrienols in preneoplastic and neoplastic mammary epithelial cells.
Proc. Soc. Exper. Biol. Med., 224: 292-301. |
| 40. |
Briski, K.P.*, Marshall E.S. (2000) Caudal brainstem Fos expression is restricted to periventricular
catecholaminergic loci following intraventricular administration of 2-deoxy-D-glucose.
Exper. Brain Res., 133: 547-551 |
| 39. |
Briski, K.P.*, Brandt, J.A. (2000) Oxytocin and vasopressin neurons in principal and accessory
hypothalamic magnocellular structures express Fos-immunoreactivity in response to
acute glucose deprivation. J. Neuroendocrinology, 12: 409-414. |
| 38. |
Mcintyre, B.S., Briski, K.P.*, Tirmenstein, M., Fariss, M.W., Gapor, A., Sylvester, P.W. (2000) Differential
antiproliferative and apoptotic effects of tocopherols and tocotrienols in normal
mouse mammary epithelial cell. Lipids, 35(2): 171-80. |
| 37. |
Briski, K.P.* (2000) Intraventricular 2-deoxy-D-glucose induces Fos expression by hypothalamic
vasopressin, but not oxytocin neurons. Brain Res. Bull., 51: 275-280. |
| 36. |
Briski, K.P.* (1999) Pharmacological manipulation of central nitric oxide/guanylate cyclase
activity alters Fos expression by hypothalamic vasopressinergic neurons during glucoprivation.
J. Chem. Neuroanatomy, 17: 13-19. |
| 35. |
Briski, K.P.* (1999) Intraventricular lactate infusion attenuates transactivational effects
of the glucose antimetabolite, 2-deoxy-D-glucose, on hypothalamic vasopressinergic
neurons. Brain Research, 839: 341-345. |
| 34. |
Briski, K.P.*, Teodecki, E. (1999) Effects of mu and kappa opioid receptor antagonists on glucoprivic
induction of Fos immunoreactivity in the rat preoptic area and hypothalamus. Brain
Res. Bull., 49: 181-187. |
| 33. |
Briski, K.P.* (1999) Glucoprivic induction of nuclear Fos-immunoreactivity in NADPH-diaphorase-containing
neurons in the rat caudal brainstem. Histochem. Cell Biol., 111: 229-233. |
| 32. |
Briski, K.P.*, Sylvester, P.W. (1999) Site-specific induction of Fos-immunoreactivity in preoptic
and hypothalamic NADPH-positive neurons during glucoprivation. Neuroendocrinology,
69: 181-190. |
| 31. |
Briski, K.P.*, Sylvester, P.W. (1998) Effects of the glucose antimetabolite, 2-deoxy-D-glucose
(2-DG), on the LH surge and Fos expression by preoptic GnRH neurons in ovariectomized,
steroid-primed rats. J. Neuroendocrinology 10: 769-776. |
| 30. |
Mcintyre, B.S., Briski, K.P.*, Hosick, H.L., Sylvester, P.W. (1998) Effect of protein tyrosine phosphatase inhibitors
on EGF- and insulin-dependent mammary epithelial cell growth. Proc. Soc. Exper. Biol.
Med. 217: 180-187. |
| 29. |
Briski, K.P.* (1997) Induction of cFos expression in hypothalamic dopaminergic neurons by the
glucose antimetabolite, 2-deoxy-D-glucose: site-specific modulation by estradiol.
NeuroReport 9: 289-295. |
| 28. |
Briski, K.P.*, Dipasquale, B.M., Gillen E. (1997) Induction of immediate-early gene expression
in preoptic and hypothalamic neurons by the glucocorticoid receptor agonist, dexamethasone.
Brain Research 768: 185-196. |
| 27. |
Gillen, E., Briski, K.P.* (1997) Induction of Fos-related antigen (FRA) immunoreactivity in the preoptic
area and hypothalamus of the rat brain by intracerebral or peripheral administration
of colchicine. Neurochem. Research 22: 549-554. |
| 26. |
Briski, K.P.* (1997) Central opioid receptors mediate inhibition of pituitary luteinizing hormone
secretion by the glucose antimetabolite, 2-deoxy-D-glucose. Amer. J. Physiology 272:
E517-522. |
| 25. |
Birkenfeld, H.P., Mcintyre, B.S., Briski, K.P.*, Sylvester, P.W. (1997) Protein kinase C isoenzyme expression in normal mouse
mammary epithelial cells grown in primary vulture. Proc. Soc. Exper. Biol. Med. 213:
65-70. |
| 24. |
Briski, K.P*. (1996) Stimulatory versus inhibitory effects of acute stress on circulating luteinizing
hormone: effects of prior exposure to glucocorticoids. Pharmacol., Biochem. & Behavior
55: 19-26. |
| 23. |
Briski, K.P.*, Sylvester, P.W. (1996) Size and charge heterogeneity of pituitary and plasma
prolactin in male rats. Neuroendocrinology 63: 437-445. |
| 22. |
Birkenfeld, H.P., Mcintyre, B.S., Briski, K.P.*, Sylvester, P.W. (1996) Role of protein kinase C in modulating epidermal growth
factor- and phorbol ester-induced mammary epithelial cell growth in vitro. Exper.
Cell Research 223: 183-191. |
| 21. |
Briski, K.P.*, Vogel, K.L., Mcintyre, A.R. (1995) The antiglucocorticoid, RU486, attenuates
stress-induced decreases in plasma luteinizing hormone concentrations in male rats.
Neuroendocrinology 61: 638-645. |
| 20. |
Briski, K.P.*, Vogel, K.L. (1995) Role of endogenous opioid peptides in central glucocorticoid
receptor (GR) - induced decreases in circulating LH. Neuropeptides 28: 175-181. |
| 19. |
Briski, K.P.* (1995) Effects of peripheral versus central administration of the endogenous glucocorticoid,
corticosterone, and the glucocorticoid receptor agonist, RU 28362, on LH levels in
male rats. Brain Research 670: 66-74. |
| 18. |
Briski, K.P.*, Sylvester, P.W. (1994) Antagonism of type II, but not type I glucocorticoid receptors
results in elevated basal luteinizing hormone release in male rats. Neuroendocrinology
60: 601-608. |
| 17. |
Sylvester, P.W., Birkenfeld, H.P., Hosick, H.L., Briski, K.P.* (1994) Fatty acid modulation of epidermal growth factor-induced mouse mammary
epithelial cell proliferation in vitro. Exper. Cell Research 214: 145-153. |
| 16. |
Sylvester, P.W., Ip, M.M., Briski, K.P.* (1993) Effects of specific fatty acids on prolactin-induced Nb2 lymphoma cells.
Life Sciences 52: 1977-1984. |
| 15. |
Briski, K.P.*, Sylvester, P.W. (1992) Differential impact of naltrexone on luteinizing hormone
release during single versus repetitive exposure to restraint stress. Psychoneuroendocrinology
17: 125-133. |
| 14. |
Briski, K.P.*, Sylvester, P.W. (1992) Inhibition of pituitary bioactive prolactin secretion
in the male rat by the glucocorticoid agonist, decadron phosphate. Biol. Reprod.
47: 478-484. |
| 13. |
Briski, K.P.*, Sylvester, P.W. (1991) Effect of naltrexone on stress-induced bioactive prolactin
release in aging male rats. Neurobiology of Aging 12: 145-149. |
| 12. |
Briski, K.P.*, Sylvester, P.W. (1991) Acute inhibition of pituitary LH release in the male rat
by the glucocorticoid agonist, decadron phosphate. Neuroendocrinology 53: 313-320. |
| 11. |
Briski, K.P.*, Sylvester, P.W. (1990) Comparative effects of various stressors on immunoreactive
versus bioactive prolactin release in old and young male rats. Neuroendocrinology
51: 625-631. |
| 10. |
Sylvester, P.W., Briski, K.P.* (1990) Diminished bioactivity of circulating prolactin despite increased immunoreactive
hormone release in old versus young male rats. Endocrinology 126: 746-753. |
| 9. |
Briski, K.P.*, Sylvester, P.W. (1988) Effects of specific acute stressors on LH release in ovariectomized
and ovariectomized estrogen-treated female rats. Neuroendocrinology 47: 194-202. |
| 8. |
Briski, K.P.*, Sylvester, P.W. (1987) Effects of repetitive daily acute stress on pituitary
LH and prolactin release during exposure to the same stressor or to a second novel
stress. Psychoneuroendocrinology 10: 95-102. |
| 7. |
Briski, K.P.*, Sylvester, P.W. (1987) Effects of sequential acute stress exposure on stress-induced
pituitary luteinizing hormone and prolactin release. Life Sciences 41: 1249-1255. |
| 6. |
Sylvester, P.W., Sarkar, D.K., Briski, K.P.*, Meites, J. (1985) Relationship of gonadal steroids to differential LH release
in response to naloxone in prepuberal male and female rats. Neuroendocrinology 40:
165-170. |
| 5. |
Meites, J., Briski, K.P.* (1984) Relation of endogenous opiates to secretion of gonadotropins. In: Hormonal
Control of the Hypothalamic-Pituitary-Gonadal Axis. KW Kearns, Z Naor, eds; Plenum
Press, New York ; pp. 509-518. |
| 4. |
Briski, K.P.*, Quigley, K., Meites, J. (1984) Counteraction by naltrexone of stress-induced
inhibition of TSH release: role of adrenergic system. Proc. Soc. Exp. Biol. Med.
177: 354-359. |
| 3. |
Briski, K.P.*, Quigley, K., Meites, J. (1984) Counteraction by morphine of stress-induced inhibition
of growth hormone release in the rat. Proc. Soc. Exp. Biol. Med. 177: 137-142. |
| 2. |
Briski, K.P.*, Quigley, K., Meites, J. (1984) Endogenous opiate involvement in acute and chronic
stress-induced changes in plasma LH concentrations in the male rat. Life Sciences
34: 2485-2493. |
| 1. |
Briski, K.P.*, Baker, B.L., Christensen, A.K. (1983) Effect of ovariectomy on the hypothalamic
content of immunoreactive gonadotropin-releasing hormone in the female mouse as revealed
by quantitative immunocytochemistry and radioimmunoassay. Amer. J. Anat. 166: 187-208. |
